Publications by authors named "Amber B Koehler"

Claim this Profile
C
Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study.
Mazie Tsang, Paul J Hampel, Kari G Rabe, Christian Brieghel, Wei Ding, Amber B Koehler

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis.
Samuel Kosydar, William J Archibald, Paul J Hampel, Timothy G Call, Sara J Achenbach, Amber B Koehler

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia.
Rachel J Bailen, Monica I Aasum, Linda M Tamminga, Amber B Koehler, Amy L Behnken

J Oncol Pharm Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.
Paul J Hampel, Kari G Rabe, Yucai Wang, Steven R Hwang, Saad S Kenderian, Amber B Koehler

Leukemia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism.
Amber B Koehler, Kari G Rabe, Daniel J Crusan, Timothy G Call, Sara J Achenbach

J Thromb Haemost· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia.
Georgios Christopoulos, Zachi I Attia, Sara J Achenbach, Kari G Rabe, Timothy G Call, Amber B Koehler

JACC CardioOncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
Samuel R Kosydar, Sameer A Parikh, Scott C Lester, Kari G Rabe, Wei Ding, Amber B Koehler

Am J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study.
Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander

Am J Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia.
Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Amber B Koehler

Br J Haematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Amber B Koehler

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
Eli Muchtar, Amber B Koehler, Michael J Johnson, Kari G Rabe, Wei Ding

Am J Hematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index.
Yucai Wang, Sara J Achenbach, Kari G Rabe, Tait D Shanafelt, Timothy G Call, Amber B Koehler

Blood Cancer J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Sameer A Parikh, Kari G Rabe, Neil E Kay, Timothy G Call, Wei Ding, Amber B Koehler

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of del6q23 in chronic lymphocytic leukemia.
Hadiyah Y Audil, Paul J Hampel, Daniel L Van Dyke, Sara J Achenbach, Kari G Rabe, Amber B Koehler

Am J Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
Yucai Wang, Sutapa Sinha, Linda E Wellik, Charla R Secreto, Karen L Rech, Amber B Koehler

Blood Cancer J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
Paul J Hampel, Sameer A Parikh, Timothy G Call, Mithun V Shah, N Nora Bennani, Amber B Koehler

Blood Cancer J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.
William J Archibald, Kari G Rabe, Brian F Kabat, Joerg Herrmann, Wei Ding, Amber B Koehler

Ann Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.
Paul J Hampel, Timothy G Call, Kari G Rabe, Wei Ding, Eli Muchtar, Amber B Koehler

Oncologist· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor.
Yucai Wang, Kari G Rabe, Michael S Bold, Min Shi, Curtis A Hanson, Amber B Koehler

Haematologica· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.
Amber B Koehler, Nelson Leung, Timothy G Call, Kari G Rabe, Sara J Achenbach

Leuk Lymphoma· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.
Sameer A Parikh, Sara J Achenbach, Timothy G Call, Kari G Rabe, Wei Ding, Amber B Koehler

Cancer Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center.
Yucai Wang, Marcella A Tschautscher, Kari G Rabe, Timothy G Call, Jose F Leis, Amber B Koehler

Haematologica· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.
Paul J Hampel, Timothy G Call, Wei Ding, Eli Muchtar, Saad S Kenderian, Amber B Koehler

Am J Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.
Paul J Hampel, Wei Ding, Timothy G Call, Kari G Rabe, Saad S Kenderian, Amber B Koehler

Leuk Lymphoma· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probable Invasive Pulmonary Cryptococcosis and Possible Cryptococcal Empyema in CLL Treated With Frontline Ibrutinib.
Amber B Koehler, Prakhar Vijayvargiya, Wei Ding

Mayo Clin Proc· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis